Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

• Improve decision making
• Accelerate drug development
• Reduce development costs

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

• The information technology challenges of gene sequencing
• “Intelligent” methods for data management and customization
• System survival tips... Deciding what data to keep or delete
• New tools to keep scientists ahead of impending data torrents